PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access
Go back to PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access| Gilead Sciences (NASDAQ: GILD) | Delayed: 124.87 +1.11 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.76 | 52 Week High | $108.63 | |||
| Open | $124.30 | 52 Week Low | $71.39 | |||
| Day High | $125.17 | P/E | 68.99 | |||
| Day Low | $123.00 | EPS | $1.81 | |||
| Volume | 8,126,292 | |||||
